Nitric oxide Releasing Ultra-Slippery Antibacterial Surfaces for Urological Catheter Applications
用于泌尿导管应用的一氧化氮释放超光滑抗菌表面
基本信息
- 批准号:10759903
- 负责人:
- 金额:$ 33.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2024-07-14
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAffectAnti-Bacterial AgentsAnti-Infective AgentsAntibiotic TherapyBacteremiaBacteriaBacterial AdhesionBacteriuriaBiocompatible MaterialsBiologicalBusinessesCannulasCatheterizationCathetersCell LineCell SurvivalChronicClinicalDataDevelopmentDevicesDisinfectionElderlyEnsureEscherichia coliFormulationFortuneGoalsGrowthGuidelinesHealth Care CostsHospitalizationHospitalsHumanIn VitroIndustrializationIndwelling CatheterInfectionInflammationInfusion proceduresKidneyLeadLength of StayLettersLiquid substanceMalignant neoplasm of urinary bladderMammalian CellMarketingMechanicsMedicalMedical DeviceMethodsMicrobial BiofilmsN-acetylpenicillamineNitric OxideNitric Oxide DonorsNursing HomesOperative Surgical ProceduresPatientsPeritoneal DialysisPhasePolymersPopulationProbabilityProceduresPropertyProteinsProteus mirabilisPyelonephritisRiskSilicone OilsSmall Business Innovation Research GrantSurfaceSurface PropertiesTechnologyTubeUnited States National Institutes of HealthUrinary CatheterizationUrinary Incontinenceacute pyelonephritisaging populationantimicrobialcatheter associated UTIcommercializationcookingcytotoxicendotrachealexperiencehealthcare-associated infectionsinfection riskinsightinterestmechanical propertiesmedical complicationpreventresponseurinaryurologic
项目摘要
Abstract
Urinary catheters are one of the most widely used medical devices in a hospital setting and are expected to only
increase in growth due to the aging population. Out of all the various biomedical devices that are frequently used
in a clinical setting, urinary catheters are associated with the largest portion of medical complications related to
infection. Catheter associated urinary tract infections (CAUTIs) account for nearly 40% of all healthcare
associated infections (HAIs) and can lead to extended hospital stays for patients which in turn leads to higher
healthcare costs. To overcome this risk of infection, a catheter surface that is able to prevent bacterial adhesion
and biofilm formation while simultaneously eliminating planktonic bacteria present in the vicinity is highly
desirable. However, no long-term catheter solution has been able to accomplish this goal. Nytricx, Inc. has
developed proprietary methods and know-how developing anti-infective nitric oxide (NO) releasing interfaces
capable of effectively eliminating a wide variety of bacterial strains while being able to elicit no cytotoxic response
from mammalian cell lines. Nytricx, Inc. has also demonstrated that the liquid-infusion of silicone oil to create a
super slippery surface is able to prevent the adhesion of proteins and bacteria and thus eliminate biofilms. A
synergistic antimicrobial response is achieved by combining liquid-infused strategy and NO releasing polymers
(LINORel). The overall objective of this Phase I SBIR application is to create a long-term highly antimicrobial
urinary catheter through a combination of impregnating Foley catheters with a NO donor, S-nitroso-N-
acetylpenicillamine (SNAP), with a liquid-infused silicone oil interface and to evaluate commercialization
feasibility in terms of mechanical and biological properties.
抽象的
尿导管是医院环境中使用最广泛的医疗设备之一,预计仅
由于人口老龄化而增加的增长。在所有经常使用的生物医学设备中
在临床环境中,尿导管与与
感染。导管相关的尿路感染(CAUTIS)占所有医疗保健的近40%
相关感染(HAI),可能导致患者的住院延长,从而导致更高
医疗保健费用。为了克服这种感染的风险,能够防止细菌粘附的导管表面
生物膜形成同时消除附近存在的浮游细菌
理想。但是,没有长期导管解决方案能够实现这一目标。 Nytricx,Inc。拥有
开发的专有方法和专有技术发展抗感染一氧化氮(NO)释放界面
能够有效消除各种细菌菌株,同时不引起细胞毒性反应
来自哺乳动物细胞系。 Nytricx,Inc。还证明了硅油的液体输注以创建
超滑面能够防止蛋白质和细菌的粘附,从而消除生物膜。一个
通过结合液体注入策略和无释放聚合物来实现协同抗菌反应
(布线)。该阶段I SBIR应用的总体目标是创建长期高度抗菌剂
通过浸渍Foley导管与无供体S-硝基-N-的结合结合的尿导管
乙酰苯丙胺(SNAP),具有液态硅油界面并评估商业化
在机械和生物学特性方面的可行性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald J. Shebuski其他文献
Induction of neointimal hyperplasia by coronary angioplasty balloon overinflation: comparison of feeder pigs to Yucatan minipigs.
冠状动脉血管成形术球囊过度充气诱导新内膜增生:饲养猪与尤卡坦小型猪的比较。
- DOI:
10.1016/0002-8703(94)90505-3 - 发表时间:
1994 - 期刊:
- 影响因子:4.8
- 作者:
William R. Humphrey;Carol A. Simmons;Christopher F. Toombs;Ronald J. Shebuski - 通讯作者:
Ronald J. Shebuski
Ronald J. Shebuski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald J. Shebuski', 18)}}的其他基金
Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters
超低结垢抗感染抗血栓释放一氧化氮血管内导管
- 批准号:
10759671 - 财政年份:2020
- 资助金额:
$ 33.74万 - 项目类别:
Localized Delivery of Sirolimus to Vascular Grafts
西罗莫司局部递送至血管移植物
- 批准号:
8251068 - 财政年份:2012
- 资助金额:
$ 33.74万 - 项目类别:
Development of Platelet & Coagulation Activation Assays
血小板的发育
- 批准号:
6402965 - 财政年份:2001
- 资助金额:
$ 33.74万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Translational Multimodal Strategy for Peri-Implant Disease Prevention
种植体周围疾病预防的转化多模式策略
- 批准号:
10736860 - 财政年份:2023
- 资助金额:
$ 33.74万 - 项目类别:
Strategies to Block Skin Wound Infection by Intercepting Bacterial Cell-to-Cell Signaling
通过拦截细菌细胞间信号传导来阻止皮肤伤口感染的策略
- 批准号:
10667239 - 财政年份:2023
- 资助金额:
$ 33.74万 - 项目类别:
Nitric oxide-releasing glycosaminoglycans for treating complex wounds
释放一氧化氮的糖胺聚糖用于治疗复杂伤口
- 批准号:
10584269 - 财政年份:2023
- 资助金额:
$ 33.74万 - 项目类别:
Understanding A Molecular Cascade That Drives Neutrophil Mediated Pathology In Arthritis
了解驱动中性粒细胞介导的关节炎病理学的分子级联
- 批准号:
10658202 - 财政年份:2023
- 资助金额:
$ 33.74万 - 项目类别:
Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality
与患者死亡率增加相关的新型大肠杆菌 III 型分泌系统的表征
- 批准号:
10506437 - 财政年份:2022
- 资助金额:
$ 33.74万 - 项目类别: